Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests

Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab quality performance to point-of-care and home self-testing. Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab...

BOSTON, 19/11/2025 (informazione.news - comunicati stampa - salute e benessere)

Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab quality performance to point-of-care and home self-testing.

Ian Parfrement, Head of Near Patient Care, Roche Diagnostics: "The COVID-19 pandemic underscored the vital role of diagnostics in identifying infection earlier and more precisely to give the best chance of effective treatment. This collaboration is further evidence of the role Roche can play, as a partner to global public health bodies, in helping to reduce the spread of infectious disease in the event of a future pandemic."

Sapphiros is committed to making diagnostics simple, scalable and accessible. This partnership advances that mission and supports governments, health systems and communities in mitigating future pandemics through rapid and reliable testing.

About Sapphiros
Sapphiros, backed by KKR and Neoenta, is a privately held consumer diagnostics company. Sapphiros' portfolio of technologies and capabilities includes novel sample collection, next generation diagnostics, and extreme volume manufacturing, which help consumers and communities access important diagnostic results.

For more information visit www.sapphiros.com

For Media Relations email press@sapphiros.com

Logo - https://mma.prnewswire.com/media/1895080/Sapphiros_2025_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/sapphiros-announces-a-strategic-agreement-with-roche-providing-roche-access-to-1-billion-lateral-flow-tests-and-access-to-future-molecular-point-of-care-tests-302619517.html